101 related articles for article (PubMed ID: 25950472)
1. ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling.
Schmitt DC; Madeira da Silva L; Zhang W; Liu Z; Arora R; Lim S; Schuler AM; McClellan S; Andrews JF; Kahn AG; Zhou M; Ahn EY; Tan M
Cell Death Dis; 2015 May; 6(5):e1742. PubMed ID: 25950472
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
[TBL] [Abstract][Full Text] [Related]
3. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.
Patel Y; Shah N; Lee JS; Markoutsa E; Jie C; Liu S; Botbyl R; Reisman D; Xu P; Chen H
Oncotarget; 2016 Apr; 7(14):18295-308. PubMed ID: 26918448
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.
Huang TH; Wu F; Loeb GB; Hsu R; Heidersbach A; Brincat A; Horiuchi D; Lebbink RJ; Mo YY; Goga A; McManus MT
J Biol Chem; 2009 Jul; 284(27):18515-24. PubMed ID: 19419954
[TBL] [Abstract][Full Text] [Related]
5. miR-506 regulates breast cancer cell metastasis by targeting IQGAP1.
Sun G; Liu Y; Wang K; Xu Z
Int J Oncol; 2015 Nov; 47(5):1963-70. PubMed ID: 26398880
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
[TBL] [Abstract][Full Text] [Related]
8. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
Zhang MY; Wang LQ; Chim CS
Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a modulates ErbB2 in breast cancer.
Wang Y; Zhang X; Chao Z; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
Cell Biol Int; 2017 Jan; 41(1):93-101. PubMed ID: 27813227
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.
Lu M; Wang T; He M; Cheng W; Yan T; Huang Z; Zhang L; Zhang H; Zhu W; Zhu Y; Liu P
Oncotarget; 2017 Apr; 8(14):23008-23019. PubMed ID: 28160563
[TBL] [Abstract][Full Text] [Related]
11. ErbB2 down-regulates microRNA-205 in breast cancer.
Adachi R; Horiuchi S; Sakurazawa Y; Hasegawa T; Sato K; Sakamaki T
Biochem Biophys Res Commun; 2011 Aug; 411(4):804-8. PubMed ID: 21787752
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
Niu G; Carter WB
Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086
[TBL] [Abstract][Full Text] [Related]
13. MiR-199b-5p targets HER2 in breast cancer cells.
Fang C; Zhao Y; Guo B
J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
Kim KK; Lee JJ; Yang Y; You KH; Lee JH
Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance.
Huynh FC; Jones FE
PLoS One; 2014; 9(12):e114419. PubMed ID: 25532106
[TBL] [Abstract][Full Text] [Related]
18. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
[TBL] [Abstract][Full Text] [Related]
19. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
20. miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.
He XH; Zhu W; Yuan P; Jiang S; Li D; Zhang HW; Liu MF
Oncogene; 2016 Nov; 35(46):6015-6025. PubMed ID: 27065318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]